Oracle Corporation has released the following notice
Oracle (ORCL) has announced a proposed settlement for a shareholder derivative action. The settlement, if approved, will implement corporate governance measures for at least five years, focusing on review procedures after quarterly earnings calls. Current Oracle stockholders as of March 22, 2024, who continue to hold shares through the final fairness hearing, will be affected.
Key points:
- Settlement Fairness Hearing scheduled for November 14, 2024
- Objection deadline: October 24, 2024
- Plaintiffs' Counsel fee request capped at $700,000
- Benefits from the settlement will go to Oracle, not individual stockholders
- No proof of claim form required for stockholders
Stockholders can find more information on Oracle's investor relations website and Lead Plaintiff's Counsel's website.
Oracle (ORCL) ha annunciato un accordo proposto per un'azione derivata degli azionisti. L'accordo, se approvato, implementerà misure di governance aziendale per almeno cinque anni, concentrandosi sulle procedure di revisione dopo le chiamate trimestrali sugli utili. Gli azionisti attuali di Oracle al 22 marzo 2024, che continueranno a detenere azioni fino all'udienza finale sulla equità, saranno interessati.
Punti chiave:
- Udienza per la correttezza dell'accordo programmata per il 14 novembre 2024
- Scadenza per le obiezioni: 24 ottobre 2024
- Richiesta di compenso per l'avvocato degli attori limitata a 700.000 dollari
- I benefici dell'accordo andranno a Oracle, non agli azionisti individuali
- Nessun modulo di prova del reclamo richiesto per gli azionisti
Gli azionisti possono trovare ulteriori informazioni sul sito web delle relazioni con gli investitori di Oracle e sul sito web dell'avvocato principale degli attori.
Oracle (ORCL) ha anunciado un acuerdo propuesto para una acción derivada de accionistas. El acuerdo, si se aprueba, implementará medidas de gobernanza corporativa por un período mínimo de cinco años, centrándose en los procedimientos de revisión después de las llamadas trimestrales de ganancias. Los accionistas actuales de Oracle a partir del 22 de marzo de 2024, que continúen manteniendo acciones hasta la audiencia final de equidad, se verán afectados.
Puntos clave:
- Audiencia de correcto acuerdo programada para el 14 de noviembre de 2024
- Fecha límite de objeciones: 24 de octubre de 2024
- Solicitud de honorarios del abogado de los demandantes limitada a $700,000
- Los beneficios del acuerdo irán a Oracle, no a accionistas individuales
- No se requiere un formulario de prueba de reclamo para los accionistas
Los accionistas pueden encontrar más información en el sitio web de relaciones con inversores de Oracle y en el sitio web del abogado principal de los demandantes.
Oracle (ORCL)은 주주 파생 소송에 대한 제안된 합의를 발표했습니다. 이 합의는 승인될 경우 기업 지배구조 조치를 최소 5년 동안 시행하며, 분기 실적 발표 후 검토 절차에 집중할 것입니다. 2024년 3월 22일 기준 현재 Oracle 주주가 최종 공정성 청문회까지 주식을 보유하는 경우 영향을 받습니다.
주요 사항:
- 합의 공정성 청문회는 2024년 11월 14일로 예정되어 있습니다.
- 이의 제기 마감일: 2024년 10월 24일
- 원고 측 변호사 수임료 요청은 700,000달러로 제한됩니다.
- 합의로 인한 이익은 개인 주주가 아닌 Oracle에 귀속됩니다.
- 주주에게는 청구 증명서 양식이 필요하지 않습니다.
주주들은 Oracle의 투자자 관계 웹사이트와 원고 측 변호사 웹사이트에서 더 많은 정보를 찾을 수 있습니다.
Oracle (ORCL) a annoncé un accord proposé pour une action dérivée des actionnaires. Cet accord, s'il est approuvé, mettra en œuvre des mesures de gouvernance d'entreprise pendant au moins cinq ans, en se concentrant sur les procédures de révision après les appels trimestriels sur les bénéfices. Les actionnaires actuels d'Oracle au 22 mars 2024, qui continuent à détenir des actions jusqu'à l'audience finale sur l'équité, seront concernés.
Points clés :
- Audience de l'équité de l'accord prévue pour le 14 novembre 2024
- Délai d'opposition : 24 octobre 2024
- Demande d'honoraires des avocats des plaignants plafonnée à 700 000 $
- Les bénéfices de l'accord iront à Oracle, pas aux actionnaires individuels
- Aucun formulaire de preuve de créance requis pour les actionnaires
Les actionnaires peuvent trouver plus d'informations sur le site Web des relations avec les investisseurs d'Oracle et sur le site Web de l'avocat principal des plaignants.
Oracle (ORCL) hat eine vorgeschlagene Einigung für eine Aktionärsderivateklage angekündigt. Die Einigung, sofern sie genehmigt wird, wird Maßnahmen zur Unternehmensführung für mindestens fünf Jahre umsetzen und sich auf Prüfungsverfahren nach den vierteljährlichen Gewinnaufrufen konzentrieren. Aktuelle Oracle-Aktionäre vom 22. März 2024, die ihre Aktien bis zur endgültigen Fairness-Anhörung halten, werden betroffen sein.
Wichtige Punkte:
- Die Fairness-Anhörung zur Einigung ist für den 14. November 2024 angesetzt.
- Frist für Einwände: 24. Oktober 2024
- Gebührenantrag der Klägeranwälte auf maximal 700.000 US-Dollar begrenzt.
- Die Vorteile der Einigung gehen an Oracle, nicht an einzelne Aktionäre.
- Aktionäre benötigen kein Nachweisformular für Ansprüche.
Aktionäre finden weitere Informationen auf der Investor-Relations-Website von Oracle und der Website des Hauptanwalts der Kläger.
- Implementation of corporate governance measures for at least five years
- Review procedures established for post-earnings call statements
- No direct cost to shareholders for the settlement
- No direct financial benefit to individual shareholders from the settlement
AUSTIN, Texas, Aug. 22, 2024 (GLOBE NEWSWIRE) --
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION | ||
In re ORACLE CORPORATION STOCKHOLDER DERIVATIVE LITIGATION This Document Relates to: ALL ACTIONS | Lead Case No. 5:19-cv-00764-BLF SUMMARY NOTICE OF PENDENCY AND SETTLEMENT OF DERIVATIVE ACTION Related Derivative Case: 5:19-cv-02448-BLF | |
Judge: Hon. Beth Labson Freeman Date First Action Filed: Feb. 12, 2019 |
TO: | ALL PERSONS AND ENTITIES THAT HELD ORACLE CORPORATION (“ORACLE”) COMMON STOCK AS OF MARCH 22, 2024 AND WHO CONTINUE TO HOLD SHARES THROUGH THE DATE OF THE FINAL FAIRNESS HEARING (“CURRENT ORACLE STOCKHOLDERS”). |
PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY.
IF YOU ARE A CURRENT ORACLE STOCKHOLDER, YOUR RIGHTS WILL BE AFFECTED BY THIS SETTLEMENT.
YOU ARE HEREBY NOTIFIED of a proposed settlement (“Settlement”) of the above-referenced shareholder derivative action (the “Action”). If the Court approves the proposed Settlement, all Current Oracle Stockholders (defined below) will forever be barred from contesting the fairness, adequacy, and reasonableness of the Settlement and from pursuing the Released Plaintiffs’ Claims. All capitalized terms used in this notice that are not defined have the meanings provided in the Stipulation of Settlement entered into on March 22, 2024 (“Stipulation”), by (1) Lead Plaintiff City of Providence (“Lead Plaintiff”); (2) Lawrence J. Ellison, Safra A. Catz, and Paula R. Hurd, as Trustee of the Hurd Family Trust and personal representative of the Estate of Mark Hurd1 (the “Individual Defendants”); and (3) nominal defendant Oracle (together with the Individual Defendants, “Defendants”). THIS NOTICE PROVIDES ONLY A SUMMARY OF THE SETTLEMENT. You can obtain more information by reviewing the Stipulation, as well as the full Notice of Pendency and Settlement of Stockholder Derivative Action (“Notice”), both of which are available on Oracle’s investor relations website at https://investor.oracle.com, and on Lead Plaintiff’s Counsel’s website at www.labaton.com.
In exchange for the Settlement and the releases provided for, subject to the terms of the Stipulation, the Parties have agreed to several corporate governance measures for a period of at least five years from the Effective Date of the Settlement that implement review procedures after Oracle’s quarterly earnings conference calls and consideration of whether any correction, amendment, or change to any of the statements made during the call should be considered.
Co-Lead Counsel have not received any attorneys’ fees for their work, and will ask the Court, on behalf of Plaintiffs’ Counsel, for an award of attorneys’ fees, payment of reasonable litigation expenses, and a service award for Lead Plaintiff (“Fee and Expense Amount”). The total request by Plaintiffs’ Counsel will not exceed
PLEASE ALSO TAKE NOTICE that a Settlement Fairness Hearing will be held before United States District Judge Beth Labson Freeman on November 14, 2024, at 8:45 am., either in person at the United States District Court for the Northern District of California, San Jose Courthouse, Courtroom 3 – 5th Floor, 280 South 1st Street, San Jose, CA 95113, or by telephone or video conference (in the discretion of the Court), to consider whether the Judgment, substantially in the form of Exhibit A to the Stipulation, should be entered: (i) approving the terms of the Settlement as fair, reasonable, and adequate and in the best interests of Oracle and Oracle’s stockholders; (ii) dismissing the Action with prejudice, pursuant to the terms of the Stipulation; and (iii) ruling upon applications for the Fee and Expense Amount.
Please Note: The date and time of the Settlement Fairness Hearing may change without further written notice to Current Oracle Stockholders. Any changes and procedures related to remote participation will be posted on Oracle’s investor relations website at https://investor.oracle.com and Lead Plaintiffs’ Counsel’s website at www.labaton.com.
Any person or entity who or which owned Oracle common stock as of March 22, 2024 and continues to hold the stock as of the date of the Settlement Fairness Hearing (“Current Oracle Stockholder”) may object to the approval of the proposed Settlement and/or any application for the Fee and Expense Amount, and appear at the hearing to explain their views, provided that they file any such objections with the Court no later than October 24, 2024, according to the instructions in the full Notice. The Court can only approve or deny the proposed Settlement; it cannot change the terms of the Settlement.
Because the Settlement resolves a derivative lawsuit, which was brought on behalf of and for the benefit of Oracle rather than individual class members, the benefits from the Settlement will go to Oracle. Current Oracle Stockholders will not receive any direct payment from the Settlement and Current Oracle Stockholders cannot request exclusion.
ACCORDINGLY, THERE IS NO PROOF OF CLAIM FORM FOR STOCKHOLDERS TO SUBMIT IN CONNECTION WITH THIS SETTLEMENT.
If you have any questions regarding this notice, the Action, or the Settlement, you may contact Co-Lead Counsel:
Mark C. Molumphy, Esq.
Cotchett, Pitre & McCarthy
840 Malcolm Road, Suite 200
Burlingame, California 94010
(650) 697-6000
mmolumphy@cpmlegal.com
Alfred L. Fatale III, Esq.
Labaton Keller Sucharow LLP
140 Broadway
New York, NY 10005
(888) 219-6877
settlementquestions@labaton.com
PLEASE DO NOT CONTACT THE COURT, DEFENDANTS, OR DEFENDANTS’ COUNSEL REGARDING THIS NOTICE
DATED: August 8, 2024 | BY ORDER OF THE U.S. DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA |
____________________________
1 Defendant Mark Hurd passed away during the pendency of the Action.
FAQ
What is the proposed settlement for Oracle (ORCL) shareholder derivative action?
When is the Settlement Fairness Hearing for the Oracle (ORCL) derivative action?
What is the deadline for Oracle (ORCL) stockholders to object to the settlement?
How much are the attorneys requesting in fees for the Oracle (ORCL) settlement?